Status:
UNKNOWN
The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment
Lead Sponsor:
Heart of England NHS Trust
Conditions:
Asthma
Eligibility:
All Genders
18-80 years
Brief Summary
Phase I: To develop and validate laboratory urine and blood test for the detection of medications commonly used in the treatment of asthma Phase II: to test the developed assay in the clinic, to deter...
Detailed Description
Phase I: laboratory based study to develop LC-MS/MS assay of urine / blood to detect presence or lack asthma medication in 50 volunteers with asthma. Phase II: once the test is validated it will be te...
Eligibility Criteria
Inclusion
- Aged 18-80
- Able to give valid informed consent
- Prescribed one or more of the medications to be tested
- Able to provide a blood and urine sample
- Able to complete questionnaires in English
Exclusion
- Females who are pregnant or lactating.
- Patients known to have any blood borne virus that would render the sample hazardous. This includes Hepatitis B, Hepatitis C and HIV.
Key Trial Info
Start Date :
April 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03460106
Start Date
April 3 2018
End Date
September 30 2021
Last Update
February 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Heartlands Hospital
Birmingham, West Midlands, United Kingdom, B9 5SS